Almandil, N.B.; AlSulaiman, A.; Aldakeel, S.A.; Alkuroud, D.N.; Aljofi, H.E.; Alzahrani, S.; Al-mana, A.; Alfuraih, A.A.; Alabdali, M.; Alkhamis, F.A.;
et al. Integration of Transcriptome and Exome Genotyping Identifies Significant Variants with Autism Spectrum Disorder. Pharmaceuticals 2022, 15, 158.
https://doi.org/10.3390/ph15020158
AMA Style
Almandil NB, AlSulaiman A, Aldakeel SA, Alkuroud DN, Aljofi HE, Alzahrani S, Al-mana A, Alfuraih AA, Alabdali M, Alkhamis FA,
et al. Integration of Transcriptome and Exome Genotyping Identifies Significant Variants with Autism Spectrum Disorder. Pharmaceuticals. 2022; 15(2):158.
https://doi.org/10.3390/ph15020158
Chicago/Turabian Style
Almandil, Noor B., Abdulla AlSulaiman, Sumayh A. Aldakeel, Deem N. Alkuroud, Halah Egal Aljofi, Safah Alzahrani, Aishah Al-mana, Asma A. Alfuraih, Majed Alabdali, Fahd A. Alkhamis,
and et al. 2022. "Integration of Transcriptome and Exome Genotyping Identifies Significant Variants with Autism Spectrum Disorder" Pharmaceuticals 15, no. 2: 158.
https://doi.org/10.3390/ph15020158
APA Style
Almandil, N. B., AlSulaiman, A., Aldakeel, S. A., Alkuroud, D. N., Aljofi, H. E., Alzahrani, S., Al-mana, A., Alfuraih, A. A., Alabdali, M., Alkhamis, F. A., AbdulAzeez, S., & Borgio, J. F.
(2022). Integration of Transcriptome and Exome Genotyping Identifies Significant Variants with Autism Spectrum Disorder. Pharmaceuticals, 15(2), 158.
https://doi.org/10.3390/ph15020158